Literature DB >> 15031292

The c-Abl tyrosine kinase phosphorylates the Fe65 adaptor protein to stimulate Fe65/amyloid precursor protein nuclear signaling.

Michael S Perkinton1, Claire L Standen, Kwok-Fai Lau, Sashi Kesavapany, Helen L Byers, Malcolm Ward, Declan M McLoughlin, Christopher C J Miller.   

Abstract

The amyloid precursor protein (APP) is proteolytically processed to release a C-terminal domain that signals to the nucleus to regulate transcription of responsive genes. The APP C terminus binds to a number of phosphotyrosine binding (PTB) domain proteins and one of these, Fe65, stimulates APP nuclear signaling. Fe65 is an adaptor protein that contains a number of protein-protein interaction domains. These include two PTB domains, the second of which binds APP, and a WW domain that binds proline-rich ligands. One ligand for the Fe65WW domain is the tyrosine kinase c-Abl. Here, we show that active c-Abl stimulates APP/Fe65-mediated gene transcription and that this effect is mediated by phosphorylation of Fe65 on tyrosine 547 within its second PTB domain. The homologous tyrosine within the motif Tyr-(Leu/Met)-Gly is conserved in a variety of PTB domains, and this suggests that PTB tyrosine phosphorylation occurs in other proteins. As such, PTB domain phosphorylation may represent a novel mechanism for regulating the function of this class of protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031292     DOI: 10.1074/jbc.M311479200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.

Authors:  Matthew A Tremblay; Christopher M Acker; Peter Davies
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain.

Authors:  Sarah D Schlatterer; Matthew A Tremblay; Christopher M Acker; Peter Davies
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  Tyrosine phosphorylation of WW proteins.

Authors:  Nina Reuven; Matan Shanzer; Yosef Shaul
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-26

4.  Fasciclin II signals new synapse formation through amyloid precursor protein and the scaffolding protein dX11/Mint.

Authors:  James Ashley; Mary Packard; Bulent Ataman; Vivian Budnik
Journal:  J Neurosci       Date:  2005-06-22       Impact factor: 6.167

Review 5.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

6.  An epigenomic role of Fe65 in the cellular response to DNA damage.

Authors:  Seungjin Ryu; Francesca Teles; Giuseppina Minopoli; Tommaso Russo; Michael G Rosenfeld; Yousin Suh
Journal:  Mutat Res       Date:  2015-01-28       Impact factor: 2.433

7.  Structural and functional characterization of a novel FE65 protein product up-regulated in cognitively impaired FE65 knockout mice.

Authors:  Bethany H Cool; Galynn Zitnik; George M Martin; Qubai Hu
Journal:  J Neurochem       Date:  2009-10-27       Impact factor: 5.372

8.  Abelson Kinases Mediate the Depression of Spontaneous Synaptic Activity Induced by Amyloid Beta 1-42 Peptides.

Authors:  M Reichenstein; N Borovok; A Sheinin; T Brider; I Michaelevski
Journal:  Cell Mol Neurobiol       Date:  2020-05-12       Impact factor: 5.046

9.  Neuronal adaptor FE65 stimulates Rac1-mediated neurite outgrowth by recruiting and activating ELMO1.

Authors:  Wen Li; Ka Ming Vincent Tam; Wai Wa Ray Chan; Alex Chun Koon; Jacky Chi Ki Ngo; Ho Yin Edwin Chan; Kwok-Fai Lau
Journal:  J Biol Chem       Date:  2018-04-03       Impact factor: 5.157

10.  The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains.

Authors:  Robert Tamayev; Dawang Zhou; Luciano D'Adamio
Journal:  Mol Neurodegener       Date:  2009-07-14       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.